EGFR and cancer: Acting through both autocrine and paracrine mechanisms, TGF-α activates EGFR-dependent signaling pathways - such as the Ras/Raf/MEK/ERK and PI3K/AKT/mTOR cascades - that support cancer cell proliferation, survival, and therapeutic resistance[68].